Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD)

CUSIP: 185063104

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
76,991,404
Total 13F shares
7,942,384
Share change
+920,529
Total reported value
$23,036,168
Put/Call ratio
873%
Price per share
$2.90
Number of holders
44
Value change
+$2,760,761
Number of buys
20
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 185063104?
CUSIP 185063104 identifies CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q4 2019

As of 31 Dec 2019, Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,942,384 shares. The largest 10 holders included RTW INVESTMENTS, LP, VANGUARD GROUP INC, BlackRock Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, FIRST MANHATTAN CO, Tekla Capital Management LLC, GROUP ONE TRADING, L.P., and OXFORD ASSET MANAGEMENT LLP. This page lists 44 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.